COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN COMPARED WITH STANDARD ACEI THERAPIES FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION IN TAIWAN

被引：1
|
作者：
Fann, C. [1 ]
Chen, S. [2 ]
机构：
[1] Kainan Univ, Taoyuan, Taiwan
[2] Novartis Taiwan, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1239
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV93
引用
收藏
页码：A617 / A617
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/ VALSARTAN IN HEART FAILURE PATIENTS IN EGYPT
    Khalil, A.
    Elsisi, G.
    Mahdy, M. Abdel Meguid
    Mansy, S.
    Farouk, M.
    Seleem, M.
    Nassar, A.
    VALUE IN HEALTH, 2024, 27 (12)
  • [42] Clinical Effectiveness of Sacubitril/valsartan among Patients Hospitalized for Heart Failure with Reduced Ejection Fraction
    Greene, Stephen J.
    Lippmann, Steven J.
    Mentz, Robert J.
    Greiner, Melissa A.
    Hardy, N. Chantelle
    Chang, Chun-Lan
    Hammill, Bradley G.
    Luo, Nancy
    Samsky, Marc D.
    Heidenreich, Paul A.
    Laskey, Warren K.
    Yancy, Clyde W.
    Peterson, Pamela N.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (11) : 937 - 937
  • [43] Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
    Greene, Stephen J.
    Choi, Sujung
    Lippmann, Steven J.
    Mentz, Robert J.
    Greiner, Melissa A.
    Hardy, N. Chantelle
    Hammill, Bradley G.
    Luo, Nancy
    Samsky, Marc D.
    Heidenreich, Paul A.
    Laskey, Warren K.
    Yancy, Clyde W.
    Peterson, Pamela N.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
  • [44] Should Patients With Heart Failure With Reduced Ejection Fraction (HFrEF) be Discharged on Sacubitril/Valsartan or ACEi/ARB: A Decision Analysis Approach
    Gilstrap, Lauren
    Zipkin, Ronnie J.
    Barnes, J. Aaron
    Tosteson, Anna
    CIRCULATION, 2020, 142
  • [45] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [46] Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System
    Wang, Zhe
    Lou, Yake
    Wang, Qi
    Sun, Min
    Li, Xiaonan
    Wang, Yinghui
    Wang, Yuehui
    CLINICAL DRUG INVESTIGATION, 2023, 43 (04) : 265 - 275
  • [47] Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System
    Zhe Wang
    Yake Lou
    Qi Wang
    Min Sun
    Xiaonan Li
    Yinghui Wang
    Yuehui Wang
    Clinical Drug Investigation, 2023, 43 : 265 - 275
  • [48] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [49] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [50] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
12345